ARROWHEAD PHARMACEUTICALS, INC. (ARWR) › Operating Cash FlowARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Operating Cash FlowAnnual figures by period end, from SEC filings.2016-09-30: -$64.43M2017-09-30: -$23.94M2018-09-30: -$47.22M2019-09-30: $173.03M2020-09-30: -$95.80M2021-09-30: $171.31M2022-09-30: -$136.13M2023-09-30: -$153.89M2024-09-30: -$462.85M2025-09-30: $179.55M$179.55M2016-09-30Operating Cash Flow (USD)2025-09-30Period endedOperating Cash FlowChange YoYSource filing2025-09-30$179.55M—2025-11-25From 2024-10-012024-09-30-$462.85M—2025-11-25From 2023-10-012023-09-30-$153.89M—2025-11-25From 2022-10-012022-09-30-$136.13M-179.5%2024-11-26From 2021-10-012021-09-30$171.31M—2023-11-29From 2020-10-012020-09-30-$95.80M-155.4%2022-11-28From 2019-10-012019-09-30$173.03M—2021-11-22From 2018-10-012018-09-30-$47.22M—2020-11-23From 2017-10-012017-09-30-$23.94M—2019-11-25From 2016-10-012016-09-30-$64.43M—2018-12-11From 2015-10-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)